Expected earnings - Kiniksa Pharmaceuticals International plc
Source: US Earnings Reports
Kiniksa Pharmaceuticals International plc (KNSA) is expected to report $0.29 for Q4 2025
Kiniksa Pharmaceuticals International plc
NASDAQ: KNSA
KNSA Trading
-1.18% G/L:
$45.30 Last:
125,068 Volume:
$46.44 Open:
KNSA Latest News
April 08, 2026 08:00:00 am
Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent PericarditisFebruary 25, 2026 04:01:00 pm
Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care ConferenceFebruary 24, 2026 07:30:00 am
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio ExecutionKNSA Stock Data
$3,390,723,279
40,262,707
0.03%
71
N/A
Biotechnology & Life Sciences
Healthcare
BM
London
